Little is known about side effects of micafungin in extremely low birthweight (ELBW) infants. In a retrospective single center study 19 ELBW infants were analyzed for micafungin efficacy and safety. At a mean±SD daily dosage of 7.5 ± 2.0mg/kg no clinically relevant side effects were observed. A significant increase of liver enzymes was reversible after treatment.
1 Department of Pediatrics, Division of Neonatology, Pediatric Intensive Care Medicine and Neuropediatrics, Medical University of Vienna, Vienna, Austria
2 Precision Vaccines Program, Department of Medicine, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Massachusetts, USA
3 Harvard Medical School, Boston, Massachusetts, USA
The authors have no conflicts of interest or funding to disclose.
Corresponding Author: Simone S. Schüller, MD, Department of Medicine, Division of Infectious Diseases, 300 Longwood Avenue, Boston, Massachusetts 02115, Phone: 617-919-2906 | Fax: 617-730-0254, firstname.lastname@example.org